Globe Life stock slips as analysts keep a moderate buy
Published on 09/18/2026 at 21:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Globe Life stock (ISIN US37959E1029) closed at USD 172.26 on September 17, 2026, down 0.4 percent from the prior regular session close. MarketBeat said 11 brokerages still rate the shares a Moderate Buy and see an average 12-month target of USD 191.67.
Analyst support still frames the move
According to ad hoc news, the latest roundup counts eight buy ratings, one strong buy and two holds for Globe Life. The same report says the average target stands at USD 191.67, which leaves the stock about 11.3 percent below that level at the September 17, 2026 close.
That same MarketBeat-backed summary also puts Globe Life's most recent quarterly revenue at USD 1.60 billion and adjusted EPS at USD 3.61. It says the quarter came in below the USD 3.67 consensus and that the board authorized a USD 2.5 billion share repurchase program.
Revenue and EPS set the tone
The combination matters more than the daily move. Revenue of USD 1.60 billion and EPS of USD 3.61 show a still-solid quarter, while the USD 0.06 EPS miss gives the stock a clear comparison point for the next analyst update or earnings print.
Market levels remain the reference
Globe Life traded at USD 172.26 on the NYSE on September 17, 2026, with an indicated after-market level of USD 172.00 later that day. FXEmpire data in the same report also showed a classic pivot around USD 173.44, placing the shares just below a short-term balance zone.
Globe Life stock at a glance
- Company: Globe Life Inc.
- ISIN: US37959E1029
- Ticker: GL
- Trading venue: NYSE
- Price (as of September 17, 2026): USD 172.26
- Market capitalization: USD 15.53 billion (as of September 18, 2026)
- Sector / Industry: Financials / Insurance - Life & Health
- Index membership: S&P 500
